Abstract:Objective: Colorectal cancer (CRC) is the third cause of expected cancer deaths both in men and women in the U.S. and the third most commonly diagnosed cancer in China Targeted therapy has been proven to improve overall survival for unresectable metastatic CRC. But the location of the primary tumor or the presence of various core driver gene mutations that confer resistance may limit the utility of targeted therapy. Therefore, it is of great significance to further elucidate novel mechanisms of invasion and metastasis of CRC and find potential novel therapeutic targets. Protein Kinase C Delta (PKC delta) plays an important role in various diseases, including tumors. In CRC, the function of PKC delta on proliferation and differentiation is mostly studied but various research results were reported. Therefore, the role of PKC delta in CRC needs to be further studied, especially in tumor invasion and metastasis in CRC which few studies have looked into.Methods: The expression of PRKCD was analyzed by the Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases and Immunohistochemical (IHC). Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) enrichment analysis were used to explore the biological functions and pathways related to PRKCD. Lentivirus transfection was used to construct CRC cell lines with overexpression and knock-down of PKC delta or N-myc Downstream Regulated Gene 1 (NDRG1). Cell invasion and migration assay, wound healing assay were used to detect the function of PKC delta and NDRG1 in the invasion and migration of cells. Flow cytometry analysis was used to detect the influence of PKC delta on the CRC cell cycles .Immunofluorescence histochemistry ,Immunoprecipitation Assay and qPCR were used to detect the relationship of PKC delta and NDRG1. Xenograft model was used to verify the role of PKC delta in vivo.Results: PKC delta is overexpressed in CRC and could promote Epithelial-Mesenchymal Transition (EMT) and the invasion and migration of CRC in vitro. We confirmed that PKC delta and the tumor suppressor factor NDRG1 had a co-localization relationship in CRC. PKC delta inhibited NDRG1 transcription and protein expression. Overexpressing NDRG1 could inhibit the function of PKC delta in promoting tumor invasion and migration. PKC delta could regulate c-Myc, one transcription factor of NDRG1, to down-regulate NDRG1. In vivo, overexpressing PKC delta could promote xenograft growth and volume. Thus, our results showed that PKC delta reduced the expression of NDRG1 through c-Myc, promoting the invasion and migration of CRC through promoting EMT.Conclusion: The increased expression of PKC delta in CRC tumor tissue could promote the invasion and migration of tumor cells, and one of the mechanisms may be regulating c-Myc to inhibit the expression of NDRG1 and promote EMT.

PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer

DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.

GPRIN1 promotes gallbladder cancer progression through the CDK1 pathway

Upregulation of PAIP1 promotes the gallbladder tumorigenesis through regulating PLK1 level

Supplementary Data from Down-Regulation of 3-Phosphoinositide–dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells

Prohibitin Overexpression Predicts Poor Prognosis and Promotes Cell Proliferation and Invasion Through ERK Pathway Activation in Gallbladder Cancer

STYK1 Promotes Cancer Cell Proliferation and Malignant Transformation by Activating PI3K-AKT Pathway in Gallbladder Carcinoma.

P21-Activated Protein Kinase 1 Induces the Invasion of Gastric Cancer Cells Through C-Jun NH2-terminal Kinase-Mediated Activation of Matrix Metalloproteinase-2

KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer

PP4R1 promotes glycolysis and gallbladder cancer progression through facilitating ERK1/2 mediated PKM2 nuclear translocation

Up-regulation of PKM2 Promote Malignancy and Related to Adverse Prognostic Risk Factor in Human Gallbladder Cancer

PCBP1 is an important mediator of TGF-β-induced epithelial to mesenchymal transition in gall bladder cancer cell line GBC-SD

DKC1 aggravates gastric cancer cell migration and invasion through up-regulating the expression of TNFAIP6

PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway

PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling

SDC1 knockdown induces epithelial–mesenchymal transition and invasion of gallbladder cancer cells via the ERK/Snail pathway

PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway

PKC delta promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway

Apkcι Promotes Gallbladder Cancer Tumorigenesis and Gemcitabine Resistance by Competing with Nrf2 for Binding to Keap1

PDK1 Promotes Tumor Growth and Metastasis in a Spontaneous Breast Cancer Model

Tumor Suppressor LKB1 Inhibits the Progression of Gallbladder Carcinoma and Predicts the Prognosis of Patients with This Malignancy